| Bioactivity | BTR-1 is an active anti-cancer agent, causes S phase arrest, and affects DNA replication in leukemic cells. BTR-1 activates apoptosis and induces cell death[1]. | ||||||||||||
| Invitro | BTR-1 (10, 50, 100, and 250 µM, 5 days) dose-dependently causes cytotoxicity in human leukemic cells, with IC50s of 8 and 6 µM at 48 and 72 h, respectively[1]. Cell Viability Assay[1] Cell Line: | ||||||||||||
| Name | BTR-1 | ||||||||||||
| CAS | 18331-34-5 | ||||||||||||
| Formula | C12H11NOS2 | ||||||||||||
| Molar Mass | 249.35 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|